Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Speechless - Fire them all, really.

<< Previous

Bullboard Posts

Next >>

Comment by houbahopon Jul 13, 2023 10:10am

132 Views

Post# 35539146

RE:RE:Speechless - Fire them all, really.

" ...Of course, Marathon and our interests may largely overlap right now but it is possible at some point in the future Marathon's own interests in getting their money back differ from ours. We are not at that point and hopefully never will be."

Hopeful is the sentiment most here have been for the last 2 years.

Marathon is a creditor to Theratechnologies to make money, not hopefulness.

It will be interesting to see the future unwind.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario